Childhood chronic lymphocytic leukemia with t(2; 14) translocation

Galina Yoffe; Patricia N. Howard-Peebles; R. Graham Smith; Philip W. Tucker; George R. Buchanan

doi:10.1016/S0022-3476(05)81658-0

Childhood chronic lymphocytic leukemia with t(2; 14) translocation

Galina Yoffe, Patricia N. Howard-Peebles, R. Graham Smith, Philip W. Tucker, George R. Buchanan

Research output: Contribution to journal › Article › peer-review

Original language	English (US)
Pages (from-to)	114-117
Number of pages	4
Journal	The Journal of pediatrics
Volume	116
Issue number	1
DOIs	https://doi.org/10.1016/S0022-3476(05)81658-0
State	Published - Jan 1990

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health

Access to Document

10.1016/S0022-3476(05)81658-0

Cite this

@article{51d720f2b40a4e12b78d761cfee47a80,

title = "Childhood chronic lymphocytic leukemia with t(2; 14) translocation",

author = "Galina Yoffe and Howard-Peebles, {Patricia N.} and Smith, {R. Graham} and Tucker, {Philip W.} and Buchanan, {George R.}",

note = "Funding Information: CASE REPORTS Patient 1. A 10-year-old white girl came in March 1982 to the Children's Medical Center of Dallas with generalized lymphadenopathy, mild hepatosplenomegaly, hypogammaglobulinemia, and leukocytosis (leukocyte count 35,900/mm 3 with 88% small mature Supported in part by an American Cancer Society Clinical Fellowship granted to Dr. Yoffe and by the Children's Cancer Fund of Dallas. Submitted for publication June 2, 1989; accepted July 13, 1989. Reprint requests: George R. Buchanan, MD, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9063. 9/22/15256 lymphocytes on the peripheral blood smear.) Chromosomal analysis revealed transloeation t(2;14) with breakpoints at or near the kappa light-chain and heavy-chain gene loci. Subsequent molecular analysis revealed the breakpoints within a DNA sequence telomere to the immunoglobulin kappa llght-chain locus on chromosome 2.12 The detailed morphologic description and immunologic studies that established the diagnosis of CLL and an account of the initial management of this patient were published previously. 8 During the first year after diagnosis, the disease was indolent and required no therapy. However, in the second and third year, disease progression was noted. Oral chemotherapy with prednisone and chlorambucil was instituted, and the patient achieved a rapid response, remaining well (but requiring continued chlorambucil) for almost 4 years. Subsequently, the disease progressed and became",

year = "1990",

month = jan,

doi = "10.1016/S0022-3476(05)81658-0",

language = "English (US)",

volume = "116",

pages = "114--117",

journal = "The Journal of pediatrics",

issn = "0022-3476",

publisher = "Mosby Inc.",

number = "1",

}

TY - JOUR

T1 - Childhood chronic lymphocytic leukemia with t(2; 14) translocation

AU - Yoffe, Galina

AU - Howard-Peebles, Patricia N.

AU - Smith, R. Graham

AU - Tucker, Philip W.

AU - Buchanan, George R.

N1 - Funding Information: CASE REPORTS Patient 1. A 10-year-old white girl came in March 1982 to the Children's Medical Center of Dallas with generalized lymphadenopathy, mild hepatosplenomegaly, hypogammaglobulinemia, and leukocytosis (leukocyte count 35,900/mm 3 with 88% small mature Supported in part by an American Cancer Society Clinical Fellowship granted to Dr. Yoffe and by the Children's Cancer Fund of Dallas. Submitted for publication June 2, 1989; accepted July 13, 1989. Reprint requests: George R. Buchanan, MD, Department of Pediatrics, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd., Dallas, TX 75235-9063. 9/22/15256 lymphocytes on the peripheral blood smear.) Chromosomal analysis revealed transloeation t(2;14) with breakpoints at or near the kappa light-chain and heavy-chain gene loci. Subsequent molecular analysis revealed the breakpoints within a DNA sequence telomere to the immunoglobulin kappa llght-chain locus on chromosome 2.12 The detailed morphologic description and immunologic studies that established the diagnosis of CLL and an account of the initial management of this patient were published previously. 8 During the first year after diagnosis, the disease was indolent and required no therapy. However, in the second and third year, disease progression was noted. Oral chemotherapy with prednisone and chlorambucil was instituted, and the patient achieved a rapid response, remaining well (but requiring continued chlorambucil) for almost 4 years. Subsequently, the disease progressed and became

PY - 1990/1

Y1 - 1990/1

UR - http://www.scopus.com/inward/record.url?scp=0025117712&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025117712&partnerID=8YFLogxK

U2 - 10.1016/S0022-3476(05)81658-0

DO - 10.1016/S0022-3476(05)81658-0

M3 - Article

C2 - 2295951

AN - SCOPUS:0025117712

SN - 0022-3476

VL - 116

SP - 114

EP - 117

JO - The Journal of pediatrics

JF - The Journal of pediatrics

IS - 1

ER -

Childhood chronic lymphocytic leukemia with t(2; 14) translocation

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this